Logo image of AGH

AUREUS GREENWAY HOLDINGS INC (AGH) Stock Fundamental Analysis

NASDAQ:AGH - Nasdaq - US05156D1028 - Common Stock - Currency: USD

3.25  +0.49 (+17.75%)

Premarket: 3.2 -0.05 (-1.54%)

Fundamental Rating

3

AGH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 131 industry peers in the Hotels, Restaurants & Leisure industry. AGH has a great financial health rating, but its profitability evaluates not so good. AGH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AGH had negative earnings in the past year.
AGH had a negative operating cash flow in the past year.
AGH Yearly Net Income VS EBIT VS OCF VS FCFAGH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 200K 400K 600K 800K

1.2 Ratios

AGH has a worse Return On Assets (-1.94%) than 70.99% of its industry peers.
With a Return On Equity value of -2.20%, AGH perfoms like the industry average, outperforming 49.62% of the companies in the same industry.
Industry RankSector Rank
ROA -1.94%
ROE -2.2%
ROIC N/A
ROA(3y)4.05%
ROA(5y)N/A
ROE(3y)17.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AGH Yearly ROA, ROE, ROICAGH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 40

1.3 Margins

AGH's Gross Margin of 50.03% is in line compared to the rest of the industry. AGH outperforms 58.02% of its industry peers.
In the last couple of years the Gross Margin of AGH has declined.
The Profit Margin and Operating Margin are not available for AGH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5YN/A
AGH Yearly Profit, Operating, Gross MarginsAGH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40

More info and screens

9

2. Health

2.1 Basic Checks

AGH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AGH has less shares outstanding
Compared to 1 year ago, AGH has an improved debt to assets ratio.
AGH Yearly Shares OutstandingAGH Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
AGH Yearly Total Debt VS Total AssetsAGH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

An Altman-Z score of 56.35 indicates that AGH is not in any danger for bankruptcy at the moment.
AGH has a better Altman-Z score (56.35) than 99.24% of its industry peers.
AGH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 56.35
ROIC/WACCN/A
WACC8.95%
AGH Yearly LT Debt VS Equity VS FCFAGH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200K 400K 600K 800K 1M

2.3 Liquidity

AGH has a Current Ratio of 9.35. This indicates that AGH is financially healthy and has no problem in meeting its short term obligations.
AGH has a Current ratio of 9.35. This is amongst the best in the industry. AGH outperforms 98.47% of its industry peers.
A Quick Ratio of 9.28 indicates that AGH has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 9.28, AGH belongs to the top of the industry, outperforming 98.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.35
Quick Ratio 9.28
AGH Yearly Current Assets VS Current LiabilitesAGH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for AGH have decreased strongly by -160.79% in the last year.
AGH shows a decrease in Revenue. In the last year, the revenue decreased by -7.21%.
Measured over the past years, AGH shows a quite strong growth in Revenue. The Revenue has been growing by 11.03% on average per year.
EPS 1Y (TTM)-160.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7%
Revenue 1Y (TTM)-7.21%
Revenue growth 3Y11.03%
Revenue growth 5YN/A
Sales Q2Q%-14.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AGH Yearly Revenue VS EstimatesAGH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AGH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AGH Price Earnings VS Forward Price EarningsAGH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AGH Per share dataAGH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15 0.2 0.25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AGH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUREUS GREENWAY HOLDINGS INC

NASDAQ:AGH (8/5/2025, 8:00:00 PM)

Premarket: 3.2 -0.05 (-1.54%)

3.25

+0.49 (+17.75%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.13%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap142.25M
AnalystsN/A
Price TargetN/A
Short Float %0.39%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 46.29
P/FCF N/A
P/OCF N/A
P/B 12.65
P/tB 12.65
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.07
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -2.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.03%
FCFM N/A
ROA(3y)4.05%
ROA(5y)N/A
ROE(3y)17.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5YN/A
F-Score2
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.6%
Cap/Sales 1.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.35
Quick Ratio 9.28
Altman-Z 56.35
F-Score2
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)111.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-160.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.21%
Revenue growth 3Y11.03%
Revenue growth 5YN/A
Sales Q2Q%-14.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-171.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-106.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.42%
OCF growth 3Y-38.05%
OCF growth 5YN/A